These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6105 related articles for article (PubMed ID: 3493226)

  • 41. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
    Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.
    Lehmann F; Marchand M; Hainaut P; Pouillart P; Sastre X; Ikeda H; Boon T; Coulie PG
    Eur J Immunol; 1995 Feb; 25(2):340-7. PubMed ID: 7875194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A peptide derived from melanocytic protein gp100 and presented by HLA-B35 is recognized by autologous cytolytic T lymphocytes on melanoma cells.
    Vigneron N; Ooms A; Morel S; Ma W; Degiovanni G; Van den Eynde BJ
    Tissue Antigens; 2005 Feb; 65(2):156-62. PubMed ID: 15713214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
    Sensi M; Traversari C; Radrizzani M; Salvi S; Maccalli C; Mortarini R; Rivoltini L; Farina C; Nicolini G; Wölfel T
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5674-8. PubMed ID: 7777568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.
    Sun Y; Möller P; Berking C; Schlüpen EM; Volkenandt M; Schadendorf D
    Immunology; 1999 Dec; 98(4):535-40. PubMed ID: 10594685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
    Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human normal CTL clones: generation and properties.
    Zagury D; Morgan D; Lenoir G; Fouchard M; Feldman M
    Int J Cancer; 1983 Apr; 31(4):427-32. PubMed ID: 6219963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
    Saitoh S; Kurisaka M; Mori K; Maeda N; Fujimoto S
    Jpn J Cancer Res; 1997 Mar; 88(3):289-95. PubMed ID: 9140114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
    Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
    J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
    Knuth A; Danowski B; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3511-5. PubMed ID: 6610177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
    J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Western blot analysis of antigens on melanoma cells recognized by cytotoxic T cells.
    Hersey P; MacDonald M; Werkman H
    J Natl Cancer Inst; 1988 Aug; 80(11):826-35. PubMed ID: 3260628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
    Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
    Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
    Crowley NJ; Darrow TL; Quinn-Allen MA; Seigler HF
    J Immunol; 1991 Mar; 146(5):1692-9. PubMed ID: 1671580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
    Brichard VG; Herman J; Van Pel A; Wildmann C; Gaugler B; Wölfel T; Boon T; Lethé B
    Eur J Immunol; 1996 Jan; 26(1):224-30. PubMed ID: 8566071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
    Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
    J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
    J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
    Coulie PG; Karanikas V; Colau D; Lurquin C; Landry C; Marchand M; Dorval T; Brichard V; Boon T
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10290-5. PubMed ID: 11517302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.
    Schneider J; Brichard V; Boon T; Meyer zum Büschenfelde KH; Wölfel T
    Int J Cancer; 1998 Jan; 75(3):451-8. PubMed ID: 9455808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 306.